Hope W C, Welton A F, Swislocki N I
Biochim Biophys Acta. 1986 Mar 19;881(1):107-12. doi: 10.1016/0304-4165(86)90103-0.
In the course of studies of the possible regulation of cellular phospholipase A2 activities by calcium and calmodulin, it was observed that some of the commercial preparations of calmodulin contained significant phospholipase A2 activity. Six commercially available calmodulin sources were compared for the presence of contaminating phospholipase A2 activity, relative purity by SDS-gel electrophoresis, and relative biological activity in stimulating calmodulin-deficient phosphodiesterase. One of the commercial calmodulin sources contained a relatively high specific phospholipase A2 activity (1.30 +/- 0.11 nmol [1-14C]arachidonic acid released/mg protein per h) and yielded two major bands in SDS-gel electrophoresis. Two of the calmodulin sources tested were relatively free of phospholipase A2 activity, were quite pure (one band on SDS-gel) and had high biological activity in stimulating calmodulin-deficient phosphodiesterase. Thus, investigators using commercially available preparations of calmodulin should be aware of the contamination of some of these sources by phospholipase A2 activity. These findings may be of importance to investigators considering the role of calmodulin in activating a variety of calcium-dependent enzymes, including phospholipase A2.
在研究钙和钙调蛋白对细胞磷脂酶A2活性可能的调节过程中,发现一些市售的钙调蛋白制剂含有显著的磷脂酶A2活性。比较了六种市售钙调蛋白来源中是否存在污染性磷脂酶A2活性、通过SDS凝胶电泳的相对纯度以及刺激钙调蛋白缺陷型磷酸二酯酶的相对生物学活性。其中一种市售钙调蛋白来源含有相对较高的特异性磷脂酶A2活性(每小时每毫克蛋白质释放1.30±0.11 nmol [1-14C]花生四烯酸),并且在SDS凝胶电泳中产生两条主要条带。测试的两种钙调蛋白来源相对不含磷脂酶A2活性,纯度相当高(SDS凝胶上一条带),并且在刺激钙调蛋白缺陷型磷酸二酯酶方面具有高生物学活性。因此,使用市售钙调蛋白制剂的研究人员应注意其中一些来源被磷脂酶A2活性污染的情况。这些发现对于考虑钙调蛋白在激活包括磷脂酶A2在内的多种钙依赖性酶中的作用的研究人员可能具有重要意义。